Guggenheim Capital’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Guggenheim Capital’s Portfolio KYTH Stock Details KYTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-47,880	Closed	-$3.59M	–	3189
2015 Q3	$3.59M	Buy	+47,880	New	+$3.58M	0.01%	1212
2014 Q4	–	Sell	-69,856	Closed	-$2.29M	–	3191
2014 Q3	$2.29M	Buy	69,856 +10,999	+19%	+$387K	0.01%	1665
2014 Q2	$2.26M	Sell	58,857 -20,485	-26%	-$715K	0.01%	1703
2014 Q1	$3.15M	Buy	+79,342	New	+$3.55M	0.01%	1424

Guggenheim Capital's KYTH Position: Q4 2015 in Review

Guggenheim Capital sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q4 2015, closing a stake of 47,880 shares — an estimated $3.59M sold.

Guggenheim Capital first reported a position in KYTH in Q1 2014 and held it in 4 quarters. The position peaked at $3.59M in Q3 2015. 0 funds tracked by Wall St. Rank hold KYTH as of Q4 2015.

Guggenheim Capital reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q4 2015 after selling out during the quarter.
Guggenheim Capital sold 47,880 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q4 2015, an estimated $3.59M.
Guggenheim Capital first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q1 2014 and held it in 4 quarters.
Guggenheim Capital's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $3.59M in Q3 2015.
0 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q4 2015.

Based on Guggenheim Capital's 13F filing for Q4 2015, filed 16 Feb 2016.